Immunity

ISSN: 1074-7613

Journal Home

Journal Guideline

Immunity Q1 Unclaimed

Cell Press United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Immunity publishes papers that report the most important advances in immunology research. The range of subjects includes, but is not limited to, immune cell development and senescence, signal transduction, gene regulation, innate and adaptive immunity, autoimmunity, infectious disease, allergy and asthma, transplantation, and tumor immunology. We also encourage the submission of manuscripts that pertain to related areas of research but have broad implications for immune responses in all aspects of human and experimental animal biology. It has an SJR impact factor of 14,286.

Immunity focuses its scope in these topics and keywords: t, cell, cells, receptor, immune, promotes, protein, factor, formation, interactions, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

4680 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Immunity

14,286

SJR Impact factor

395

H Index

226

Total Docs (Last Year)

729

Total Docs (3 years)

14046

Total Refs

13386

Total Cites (3 years)

711

Citable Docs (3 years)

18,17

Cites/Doc (2 years)

62,15

Ref/Doc

Aims and Scope


t, cell, cells, receptor, immune, promotes, protein, factor, formation, interactions, transcription, activation, dendritic, cytokine, human, repressing, reveals, homeostasis, enteric, function, functional, gene, generation, germinal, granuloma, growth, helper,



Best articles by citations

High Glucose Intake Exacerbates Autoimmunity through Reactive-Oxygen-Species-Mediated TGF-beta Cytokine Activation

View more

RETRACTED: Autoimmunity as the Consequence of a Spontaneous Mutation in Rasgrp1

View more

The AIM2-like Receptors Are Dispensable for the Interferon Response to Intracellular DNA

View more

The Cytosolic Endopeptidase, Thimet Oligopeptidase, Destroys Antigenic Peptides and Limits the Extent of MHC Class I Antigen Presentation

View more

Mature T Cells Depend on Signaling through the IKK Complex

View more

The Histone Methyltransferase Setdb2 Modulates Macrophage Phenotype and Uric Acid Production in Diabetic Wound Repair

View more

It's a Good Year for Blimp-1 (and Plasma Cells)

View more

Paralysis of Dendritic Cell IL-12 Production by Microbial Products Prevents Infection-Induced Immunopathology

View more

A Stress-Induced, Superoxide-Mediated Caspase-1 Activation Pathway Causes Plasma IL-18 Upregulation

View more

Interleukin-27: Balancing Protective and Pathological Immunity

View more

Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

View more

Nucleic Acid-Sensing Toll-like Receptors Are Essential for the Control of Endogenous Retrovirus Viremia and ERV-Induced Tumors

View more
SHOW MORE ARTICLES

Colony-Stimulating Factor-1-Dependent Macrophages Are Responsible for IVIG Protection in Antibody-Induced Autoimmune Disease

View more

IL-4 Rapidly Produced by Vbeta4 Va8 CD4+ T Cells Instructs Th2 Development and Susceptibility to Leishmania major in BALB/c Mice

View more

IL-4 Utilizes an Alternative Receptor to Drive Apoptosis of Th1 Cells and Skews Neonatal Immunity toward Th2

View more

Intracellular Pathogens and Antigen Presentation - New Challenges with Legionella Pneumophila

View more

The Immunoglobulin Class Switch: Beyond "Accessibility"

View more

The Src Family Kinases Hck and Fgr Negatively Regulate Neutrophil and Dendritic Cell Chemokine Signaling via PIR-B

View more

Prediction and Pathogenesis in Type 1 Diabetes

View more

IL-6 trans-Signaling

View more

Biological Insights into TCR gammad+ and TCRabeta+ Intraepithelial Lymphocytes Provided by Serial Analysis of Gene Expression (SAGE)

View more

Erratum

View more

The Immunological Barrier to Xenotransplantation

View more

Cytosolic DNA Sensing: The Field Narrows

View more

Comments

No comments ... Be the first to comment!

FAQS